"Our service and quality set the standard of excellence for community health systems. In addition to being a full-service hospital we operate an extensive clinic system, from urgent care centers to specialty physician practices throughout the greater Jefferson City area and surrounding communities. Throughout our history the mission has stayed the same: to improve the health and promote the wellness of the people and communities we serve. Our board-certified physicians are ready to assist you with your family medical needs. Our physicians are currently accepting new patient and our courteous and professional staff look forward to serving you and your family."

During the past decade, Capital Region Medical Center-Goldschmidt Cancer Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 49 clinical trials were completed, i.e. on average, 326.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 24 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Region Medical Center-Goldschmidt Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 25 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Region Medical Center-Goldschmidt Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Capital Region Medical Center-Goldschmidt Cancer Center" are "Breast Cancer" (12 trials), "Colorectal Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Lung Cancer" (6 trials) and "Multiple Myeloma" (5 trials). Many other conditions were trialed in "Capital Region Medical Center-Goldschmidt Cancer Center" in a lesser frequency.

Most popular intervention types in "Capital Region Medical Center-Goldschmidt Cancer Center" are "Drug" (52 trials), "Other" (32 trials), "Biological" (19 trials), "Procedure" (6 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "placebo" (11 trials), "Docetaxel" (4 trials), "bevacizumab" (4 trials) and "rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Capital Region Medical Center-Goldschmidt Cancer Center" are 61 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Capital Region Medical Center-Goldschmidt Cancer Center". undefined are not yet recruiting, undefined are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Capital Region Medical Center-Goldschmidt Cancer Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Region Medical Center-Goldschmidt Cancer Center, 4 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".